Orforglipron coupons & savings
orforglipron · manufacturer programs, telehealth bundles, discount cards
Orforglipron is Eli Lilly's first-in-class daily oral GLP-1 receptor agonist, FDA-approved in April 2026 for chronic weight management and type 2 diabetes. Launching during $149/month direct via LillyDirect — substantially cheaper than injectable GLP-1s and first oral GLP-1 at sub-injectable pricing.
Your options
- RecommendedManufacturer
LillyDirect Direct-Pay (launch pricing)
$149/month for all approved dosesEligibility: US residents with valid orforglipron prescription. No insurance required. Launch pricing effective for first 12 months after launch; subsequent pricing TBD.
- Manufacturer
Orforglipron commercial insurance pathway (developing)
Variable copay tierEligibility: Insurance coverage is being established through 2026 as plans add orforglipron to formularies. Many commercial plans expected to add coverage by late 2026; some may require prior authorization.
Important notes
- Newly approved (April 2026) — long-term insurance coverage patterns still developing.
- Daily oral dosing (vs weekly injection); patients with needle aversion or adherence challenges may benefit from this profile.
- Trial weight loss is modestly less than injectable semaglutide or tirzepatide but comparable to oral semaglutide (Rybelsus).
More on Orforglipron
Frequently asked
What's the cheapest way to get Orforglipron?+
Based on the programs currently tracked, the lowest sticker price for Orforglipron is "LillyDirect Direct-Pay (launch pricing)" at $149/month for all approved doses. Eligibility varies by program — check the requirements for each option above before counting on a price.
Does insurance cover Orforglipron?+
Insurance coverage for Orforglipron depends on the plan and indication. Many commercial plans cover orforglipron for FDA-approved uses with prior authorization; off-label use is rarely covered. Check your formulary or run your plan through our insurance coverage tool.
Are coupons for Orforglipron legitimate?+
Manufacturer programs from Orforglipron's maker and federally registered patient assistance foundations are legitimate. Be cautious with discount cards that promise prices far below retail without verifying the dispensing pharmacy is licensed in your state.
What's the best option for Orforglipron right now?+
Editorial pick: LillyDirect Direct-Pay (launch pricing) at $149/month for all approved doses. US residents with valid orforglipron prescription. No insurance required. Launch pricing effective for first 12 months after launch; subsequent pricing TBD. This is a starting point; your situation may favor a different program based on insurance and clinical eligibility.